apitegromab tirzepatide A new phase 2 trial in Nature Medicine tested whether apitegromab, an investigational monoclonal antibody that selectively inhibits myostatin activation, could preserve lean mass during… Emerging Role of Myostatin Inhibitors
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16

















:max_bytes(150000):strip_icc()/GettyImages-1393287140-1a0a64aa9b8f4abc85356e41c0f799a2.jpg)








